Antimicrobials | CMAC

Antimicrobials

Factors affecting a variability of serum vancomycin concentrations in clinical practice

This study assessed vancomycin concentrations in standard dosing regimens in a routine clinical practice and determined factors affecting their variability. Patients with normal renal function more often experienced low trough serum vancomycin …

Antibiotic dosing in obesity: size does matter?

Currently, from 15 to 50% of the population in the developed countries has obesity. Overall, patients with obesity have a higher risk of infection; they are more likely to develop infectious complications after surgical interventions and have a …

Fluoroquinolone use restrictions in patients with uncomplicated infections and safety issues

n May 2016, US FDA advised to restrict fluoroquinolones use in patients with acute sinusitis, acute exacerbations of chronic bronchitis, and uncomplicated urinary tract infections. The reason for this decision was the new safety data obtained during …

Topical therapy of wound infections: antiseptics or antibiotics?

Wound healing and wound infection is not enough standardized in practice of surgeon. Existing recommendations on local antimicrobial agents do not contain references to specific products and do not explain their key features. The role of antiseptics …

New and old oxazolidinones: tedizolid vs. linezolid

Tedizolid is a novel oxazolidinone that has been recently approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) caused by Gram-positive pathogens, including MRSA. The mechanism of action of tedizolid is similar to …

Surveillance of antimicrobials use in neonatal hospitals with alternative DDD methods

One of the most common problems in neonatal hospitals is the choice of metrics of drugs usage in neonatology, especially use of antibiotics. This study represents our experience in quantifying antibiotic use in a Level-III neonatal intensive care …

Fluoroquinolones efficacy in acute sinusitis, acute exacerbation of chronic bronchitis and uncomplicated urinary tract infections

In May 2016 the U.S. Food and Drug Administration (FDA) approved changes to the labels of fluoroquinolone drugs for systemic use and advised to restrict their prescribing for the treatment of acute sinusitis, uncomplicated urinary tract infections …

Medication errors associated with the use of cephalosporins

Objective. To discover the prevalence and types of medication errors associated with the use of cephalosporins through analysis of national spontaneous reporting database. Materials and Methods. We conducted a retrospective analysis of 2324 spontaneous reports concerning adverse drug reactions associated with the cephalosporins. All the reports were submitted to the Russian pharmacovigilance database between 01.01.2012 and 01.08.2014. Approved prescribing drug information, standards of medical care and practical guidelines for certain conditions were used to identify medication errors associated with specific products.

Evidence Based Review on Daptomycin Use in the Treatment of Gram(+) Infections

Daptomycin is the only clinically used member of a cyclic lipopeptides class of antibiotics. Daptomycin has rapid bactericidal activity against not only rapidly growing, but also against slow growing bacterial cells including those in biofilms. …

New Drug Formulations of Posaconazole: Brief Clinical Pharmacology Review

Posaconazole is a second generation triazole with a broad spectrum of activity, which first appeared on the market in 2005 in the form of a suspension for oral administration. Despite some progress made in the framework of clinical trials, the …